Recent CCRN Stock Price | CCRN Stock Predictions | |
$11.52 | +35.42% |
$15.60 |
Recent CCRN Analyst Ratings Breakdown, Making CCRN Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 3 | 3 | 3 | 3 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 5 | 5 | 5 | 5 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.25 | 2.25 | 2.25 | 2.25 |
For the CCRN stock predictions from the analysts covering Cross Country Healthcare Inc, we have collected all of the individual CCRN stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 5 different analysts covering CCRN (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CCRN stock predictions may vary widely, another useful metric to consider is the median CCRN stock prediction, which represents the price at which half of the analysts
made CCRN stock predictions that were higher and half made CCRN stock predictions that were lower. This makes for a different take on the CCRN stock predictions out there, as compared to average or mean.
And that median across all the individual CCRN stock predictions was: $15.0 as of 2024-12-03.
The very highest of the CCRN stock predictions for one year price target was $19.0, while the very lowest of the CCRN stock predictions in the analyst group was
$12.0 (with a standard deviation of $2.88). Get the latest Zacks research report on CCRN — FREE
Find out: CCRN next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
HHR Stock Predictions
SSB Stock Predictions
FPH Stock Predictions
AQN Stock Predictions
REVG Stock Predictions
CARE Stock Predictions
HPE Stock Predictions
TRI Stock Predictions
MATX Stock Predictions
|
|
Buy (2.75 out of 4) 24th percentile
(ranked lower than approx. 76% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |